Poly Medicure Limited Submits SEBI Compliance Certificate for Quarter Ended March 2026

1 min read     Updated on 15 Apr 2026, 01:00 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Poly Medicure Limited filed its quarterly SEBI compliance certificate for Q4 FY26, confirming adherence to dematerialization regulations. The certificate, processed through registrar MAS Services Limited, verified that all securities received for dematerialization during January-March 2026 were handled within the mandated 15-day timeline, with proper documentation and register updates completed as per regulatory requirements.

powered bylight_fuzz_icon
37783828

*this image is generated using AI for illustrative purposes only.

Poly Medicure Limited has submitted its quarterly compliance certificate to stock exchanges, fulfilling regulatory requirements under SEBI's depositories regulations for the quarter ended March 31, 2026.

Regulatory Compliance Filing

The company filed the mandatory certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 on April 15, 2026. The submission was made to both BSE Limited and National Stock Exchange of India Limited through Company Secretary Avinash Chandra.

Filing Details: Information
Filing Date: April 15, 2026
Quarter Covered: January 1, 2026 to March 31, 2026
Regulation: SEBI Regulation 74(5)
Company Secretary: Avinash Chandra (M. No: A32270)

Registrar Confirmation

MAS Services Limited, serving as the company's Registrar & Share Transfer Agent, provided the confirmation certificate dated April 2, 2026. The registrar confirmed compliance with all dematerialization requirements during the specified quarter.

The registrar's certificate verified that:

  • All securities received from Depository Participants for dematerialization were confirmed within 15 days of receipt
  • Security certificates were properly mutilated and cancelled after due verification
  • Depositories were substituted as registered owners in the member register within the mandated timeline
  • Register of Members was updated accordingly

Process Compliance

Compliance Parameter: Status
Dematerialization Timeline: Within 15 days
Certificate Processing: Completed as per norms
Register Updates: Updated within prescribed limits
Stock Exchange Notification: Completed within 15 days

The filing demonstrates the company's adherence to SEBI's regulatory framework governing depositories and participants, ensuring proper handling of securities dematerialization processes during the quarter ended March 31, 2026.

Historical Stock Returns for Poly Medicure

1 Day5 Days1 Month6 Months1 Year5 Years
-0.49%+1.38%+18.72%-23.85%-39.78%+48.26%

Will Poly Medicure's consistent regulatory compliance improve its ESG ratings and attract institutional investors in the upcoming quarters?

How might the company's strong depositories compliance record impact its eligibility for inclusion in major stock indices or ETFs?

Could this regulatory adherence signal Poly Medicure's preparation for potential corporate actions like bonus issues or stock splits in 2026?

Poly Medicure Limited Schedules Additional Investor Meeting for March 30, 2026

1 min read     Updated on 25 Mar 2026, 10:24 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Poly Medicure Limited continues its investor engagement activities with the announcement of a new one-on-one meeting with Front Wave Research LLP scheduled for March 30, 2026. This adds to the company's existing meeting schedule that includes sessions with Avendus Spark and Quantum Advisors Private Limited on March 24, 2026, while maintaining full regulatory compliance under SEBI guidelines.

powered bylight_fuzz_icon
35467809

*this image is generated using AI for illustrative purposes only.

Poly medicure Limited has announced scheduled one-on-one meetings with analysts and investors, as per regulatory filings under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has informed both BSE Limited and National Stock Exchange of India Limited about these investor interactions.

March 24, 2026 Meeting Schedule

The company had previously scheduled two virtual one-on-one meetings for March 24, 2026:

S. No. Investor Meeting Date Time Venue Format
1. Avendus Spark Tuesday, 24th March, 2026 02:30 P.M. Virtual One-on-one
2. Quantum Advisors Private Limited Tuesday, 24th March, 2026 05:30 P.M. Virtual One-on-one

Latest Meeting Addition

In the latest regulatory filing dated March 25, 2026, Poly Medicure Limited has scheduled an additional investor meeting:

S. No. Investor Meeting Date Time Venue Format
1. Front Wave Research LLP Monday, 30th March, 2026 03:30 P.M. Virtual One-on-one

The company noted that confirmation for this meeting was received on shorter notice, hence the intimation is being made at a shorter notice.

Meeting Cancellation

The company had also announced the cancellation of a previously scheduled meeting with TCG Asset Management:

Investor Original Meeting Date Time Venue Format Status
TCG Asset Management Friday, 20th March, 2026 02:30 P.M. Virtual One-on-one Cancelled

Regulatory Compliance

Poly Medicure Limited has emphasized that all schedules are subject to changes due to exigencies on the part of analysts, investors, or the company. The company has specifically stated that no unpublished price sensitive information will be shared during these meetings, ensuring compliance with regulatory requirements.

The latest communication was signed by Avinash Chandra, Company Secretary (M. No. A32270), and digitally authenticated on March 25, 2026, at 15:57:48 +05'30'. The company maintains its registered office at 232 B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110 020.

Historical Stock Returns for Poly Medicure

1 Day5 Days1 Month6 Months1 Year5 Years
-0.49%+1.38%+18.72%-23.85%-39.78%+48.26%

What strategic announcements or business updates might Poly Medicure be preparing to share given the increased investor engagement activity?

How could the outcomes of these investor meetings influence Poly Medicure's stock price and trading volume in the coming weeks?

Will Poly Medicure expand its investor outreach program to include more institutional investors following these initial meetings?

More News on Poly Medicure

1 Year Returns:-39.78%